Eli Lilly (NYSE:LLY) recently received FDA approval for a new dosing schedule of Kisunla, aimed at reducing amyloid-related ...

Eli Lilly and Company (NYSE: LLY) is one of Goldman Sachs’ top healthcare stock picks. On July 9, the company confirmed the ...

Branded as Kisunla by drugmaker Eli Lilly, donanemab's approval follows years of setbacks and delays in getting the experimental Alzheimer's treatment to market, despite promising clinical trial ...

Eli Lilly says new Alzheimer's drug donanemab slows early stages of disease by 35%. ... Lilly said 52% completed their donanemab treatment within a year and 72% within 18 months.

Eli Lilly has submitted its Alzheimer’s disease drug candidate for FDA review, ... treatment with the Lilly drug led to a nearly 39% reduction in disease progression.

An experimental treatment from Eli Lilly significantly slowed cognitive and functional decline in people with early symptomatic Alzheimer’s disease in a large clinical trial, the company ...

The treatment would be the second of its kind to be authorized in the U.S. if it receives final approval. ... FDA Panel Unanimously Recommends Eli Lilly’s Alzheimer’s Drug. ByAntonio Pequeño IV, ...

The US FDA has approved donanemab, a treatment for Alzheimer's disease that is designed to slow the progression of early signs of the dementia. Made by Indianapolis-based Eli Lilly, donanemab is a ...

Pharmaceutical giant Eli Lilly said Wednesday results from a Phase 3 study on its Alzheimer's treatment show it slowed clinical cognitive and functional decline by 35% compared with a placebo.

The Eli Lilly and Co. LLY investigational Alzheimer’s treatment donanemab has shown particular promise in treating patients at younger ages and in the earliest stage of disease, according to new ...

Illimis Therapeutics’ Series B round was led by Korean venture capital firm DSC Investment. Seoul-based Illimis Therapeutics ...

FDA Approves New Alzheimer's Treatment From Eli Lilly. July 2nd, 2024. News 9 5 a.m. newscast 6/18/2025. June 18th, 2025. Man accused in fatal shooting of Oklahoma Co. deputy misses court appearance.